































1 ) Oku N., Tokudome Y., Koike C., Okada S., 
Nishikawa N., Mori H. and Saiki I.: Effective 
inhibition of metastasis by liposomal Arg-Gly-
Asp analogs. Drug Delivery System, 12(1):13-
18, 1997 (in Japanese). 
L-arginine-L glycine L-aspartic acid (RGD) 
sequence, originally found in fibronectin, one of 
main component of extracellular matrices, is konwn 
as a ligand to some adhision molecules. 
Since the interaction of metastatic tumor cells 
with target endothelium and extracellular matrices 
under it , isimportant for establishment of blood-
borne metastasis, analogs of the peptide have been 
developed for the suppression of tumor metastasis. 
In fact, some synthetic peptides having the RGD 
50 
sequence have been found to decrease metastatic 
colonization. To enhance the metastasis suppress-
ing efficacy of these analogs, we attempted to stabi-
lize and to prolong the circulation time of these 
analogs by liposomalization. 
Various structures of hydrophobized RGD ana 
logs (lipophilic antimetastatic peptides, LAPs) 
weてesynthesized, and incorporated into liposomes. 
Liposomes composed of distearoylphosphatidyl-
choline, cholesterol, dipalmitoy:lphosphatidylglyce-
rol and LAPs were injected intravenously with 
Bl6BL6 murine melanoma cells into mice. 
Liposomal RGD (0.6 μrnol of the analog equivalent 
to ca. 200 μg RGD peptides) inhibited lung coloniza-
tion up to 76%. This dose is an order of magnitude 
lower than that for comparable inhibition reported 
for free RGD. Multi dose administration of LAP 
liposomes (0.15 μmol of the analog equivalent to ca. 
50 μg RGD peptides) also inhibited the 
sponataneous lung metastasis of cells from a pri-
mary tumor site of Bl6BL6 cells subcutaniously 
implanted into the footpat of mice. 
In conclusion, liposomal RGD may be useful for 
the suppresion of tumor metastasis. 
2) Ohnishi Y., Sakamoto T., Fujii H., Kimura F., 
Murata J., Tazawa K., Fujimaki M., Sato Y., 
Kondo M., Une Y., Uchino J. and Saiki I: 
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Fig. 1 Experimental liver metasyasis by L5, M3. 
1 and P carcinoma cels. Five BALB/ c mice per 
group were inoculated with an intraportal vein 
injection of L5, M3.l and P cells ( 1×10') . 
Twenty days after tumor inoculation, the mice 
were killed and the number of liver colonies 
was manually counted (A). 
of murine colon 26 carcinoma cells. Tumor 
Biology, 18 : 113-122, 1997. 
Intraportal vein injection of highly metastatic L5 
cells consistently resulted in liver metastases 
(increases in the number of tumor colonies in the 
liver), whereas inoculation of P cells rarely did 
(Fig. 1). L5 cells invaded the basement membrane 
Matrigel in greater numbers than did P cels, sug司
gesting that metastatic potential of L5 cells is 
partly related to enhanced invasive properties. The 
enhanced adhesion of L5 cells to fibronectin , 
laminin and Matrigel coated substrates, as well as 
their haptotactic migration to fibronectin, may be 
associated with the preferential expression of VLA 
2 and VLA 4 integrins on the surface of these cells 
detected by flow cytometry. Gelatin zymography 
showed that the degradative activity of 72 kDa 
gelatinases was greater in L5 cells than P cels. 
These results indicate that the invasive ability of L5 
cells may be also due to enhanced gelatinolytic 
activity as well as adhesiveness and motility. L5 
cells grew in vitro more rapidly than P cels. Thus, 
an experimental model using highly metastatic 
colon 26 L5 cells would be useful for analyzing the 
molecular mechanism of liver metastasis and for 
evaluating the efficacy of treatment of occult mi-
crometastasis which may have been already dis-
seminated at the time of surgery. 
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本p< 0.05 compared with the group inoculated 
with P cells ；キ＊＊p<0.001compared with the 
group injected with M3.l and P cells by Studen’s 
two-tailed t test. Macroscopic observations of 
liver metastases by L5 and P cells 20 days after 
tumor inoculation (B). 
3) Oku N., Koike C., Tokudome Y., Okada S., 
Nishikawa N .,Tsukada H., Kiso M., Hasega-
wa A., Fujii H., Murata J.and Saiki I.: Appli-
cation of liposomes for cancer metastasis. 
Advanced Drug Delivery Reviews, 24 : 215 -
223, 1997. 
Metastasis is established by a complex cascade of 
activities, and adhesion of tumor cells to endothelia 
or to extracellular matrix is one of the critical steps 
in the metastatic cascade. Therefore, agents that 
supress such interaction may serve as anti metas-
tatic drugs. We previously established a non-inva-
sive method to determine metastatic tumor cell 
trafficking by use of positron emission tomography 
(PET). In this method, positron labeled metastatic 
cells are injected into bloodstream to determine 
tumor cell biodistribution in real time from immedi-
ately after injection in a living animal. Here, to 
elucidate the involvement of cellular surface adhe-
sion molecules in metastatic process, we investiga-
ted the effect of liposomalized sialyl Lewis X (sLe) 
as well as L-arginine-L-glycine-L-aspartic acid 
(RGD)-related peptide on the trafficking of 
B16BL6 melanoma cells and on metastatic poten-
tial. The trafficking of B16BL6 cells after injection 
into the tail vein was highly affected by liposomal 
sLeX, but only litle by RGD related peptide, sugges 
ting that the adhesion of metastatic cells to the 
target is initially mediated via selectin, and integrin-
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Fig. 3 Effect of liposomal RGD on experimental 
lung metastasis. Liposomal RGD伶.6μmol 
RGD derivative equivalent to ca. 200 μg as 
RGD moiety/mouse) as well as free ORGDS 
were co injected with Bl6BL6 cells ( 1×1Q5 
cells/mouse) into a tail vein of male mice (n= 
5). At day 14, the mice were sacrificed under 
anesthesia, and the metastatic colonies in lungs 
were examined. Colony numbers are expressed 
as percent of control and S.D., where the colony 
number of control was 94.8±14.9. 
• P < 0.05, * * P< 0.01 vs. PBS control. (from Ref. 
[10 J). 
Furthermore, liposomal sLe supressed experimen-
tal metastasis suggesting that adhesion via selectin 
is an important step for metastasis. Next, to 
enhance the metastasis suppressing efficacy, 
liposomalization of RGD was attempted, since RGD-
related peptides have been found to supress metas-
tastis. V aroius structures of RGD analogs grafted to 
hydrophobic groups were synthesized and then 
incorporated into liposomes (Fig. 2). Some 
liposomalized RGD markedly inhibited lung coloni-
zation at the concentration of an order of magni-
tude lower than that for comparable inhibition 
reported for free RGD (Fig. 3). The present study 
indicates that liposomal application is useful for 
both clarifying the mechanism of metastasis and the 
development of anti-metastatic pharmaceutics. 
4) Saito K. Oku T., Ata N., Miyashiro H., 
Hattori M. and Saiki I. : A modified and 
convenient method for assessing tumor cell 
invasion and migration and its application to 
52 
screening for inhibitors. Biol. Pharm. Bull., 
20 (4) : 345-348, 1997. 
In order to screen potent inhibitors of tumor 
invasion and metastasis, we here devised a simple 
and reproducible in vitro assay for tumor invasion 
and migration. A conventional cell-counting assay 
using a Transwell chamber with a microporous 
membrane filter is troublesome and time-consum-
ing, involving visually counting the cells under a 
microscope, and the invaded or migrated cells are 
sometimes distributed unevenly in predetermined 
fields on the lower surface of the filter. Therefore, 
it is difficult to evaluate the invasive and migratory 
abilities of tumor cells easily and quantitatively by 
the cell counting method. In the present study, 
crystal violet dye was used for staining the invaded 
cells and colorimetrically assessing the invasive 
ability per filter as an absorbance. In this crystal 
violet assay, tumor cell invasion into a reconstituted 
basement membrane Matrigel was proportional to 
both the cell number added into the chamber and 
the incubation period, and inversely proportional to 
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Fig. 4 Effect of Caffeic Acid and Its Related 
Compounds on the Invasion of HT-1080 Cells in 
the CrJ'."stal Violet Assay 
The invasive activity of HT 1080 cells was 
assayed in Transwell chambers. as shown in 
Fig. 3. HT 1080 cells (2.5×104 cells/0.1 ml) 
were added into the upper compartment of the 
chamber and incubated with or without caffeic 
acid, its related compounds or DOX for 4 h at
37℃. The numbers of invaded cells were asses-
sed by the crystal violet assay method, as 
shown in Fig. 1. The data were expressed as the 
mean士S.D.of triplicate cultures. 
of filter. The results obtained by this dye-uptake 
method were highly consistent with those of a 
conventional cel counting assay. Using this crystal 
violet assay, the anti-invasive effect of doxorubicin 
(DOX) was detected more easily and found to be 
highly proportional to that by the conventional cell-
counting method. We therefore applied this conve-
nient assay method to screen anti invasive and anti 
metastatic compounds. As a result, caffeic acid was 
found to be more active in the inhibition of both 
tumor cell invasion and migration without showing 
direct cytotoxicity in vitro than other related com-
pounds (Fig. 4). 
5 ) Ogasawara M., Murata J., Ayukawa K. and 
Saiki I: Differential effect of intestinal neuro-
peptides on invasion and migration of colon 
carcinoma cells in vitro. Cancer Letters, 119 : 
125-130, 1997. 
We investigated the effect of neuropeptides, 
which are vasoactive intestinal polypeptide (VIP), 
substance P (SP), neuropeptide Y (NPY), neuro-
kinin A (NKA), somatostatin (SOM), calcitonin 
gene-related peptide (CGRP), and leucine enke-
phalin (L-ENK), on the invasion of murine Colon 26-
L5 adenocarcinoma cells through a reconstituted 
basement membrane (Matrigel) using a Transwell 
cell culture chamber assay. VIP, SP, NPY, and L 
ENK reduced invasive potential of tumor cells in a 
concentration-dependent manner, whereas SOM, 
CGRP, and NKA had no effect (Fig. 5). Especially, 
VIP showed the most effective in inhibiting tumor 
invasion, and achieved 50 % reduction at 10 6 M. A 
similar effect by VIP was also observed in cell 
migration to fibronectin. VIP had no effect on the 
growth of tumor cells at the concentrations ranging 
from 10 10 to 10-6 M. The suppressed ability of the 
tumor cell motility by VIP (10 6 M) was practically 
recovered by co treatment with 2', 5’－ dideoxy 
adenosine, an adenylate cyclase inhibitor. These 
results indicate that VIP, among the neuropeptides 
used, could inhibit Matrigel invasion of Colon 26 L5 
carcinoma cells through partial suppression of their 
motility, and the reduction was associated with an 
intracellular cAMP mediated pathway. 
6) Oku T., Ata N., Yonezawa K., Tokai H., F吋i
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Fig. 5 Effect of neuropetides on invasion of Matrigel by Colon 26-L5 cels. Colon 26 
L5 cells ( 1×105) were pretreated with various concentrations of neuropeptides for 
30 min on ice. The cells were seeded onto the filters precoated with 10 μg Matrigel 
on the upper surface and 1 μg fibronectin on the lower surface in the presence or 
absence of neuropeptides in the Transwell chambers. After a 6 h incubation, the 
cells invading to the lower surface were visually counted. Mean number of invaded 
cells 111 for controLe, VIP；ム，SP；・，NPY；マ，L-ENK；企，SOM；口，CGRP;O,
NKA. Experiments were repeated three times separately, and typical data are 
repreaented. Values are indicated as mean±S.D. 
*P<O.O色村P<O.oI.
tasis. In another model using spontaneously metas 
tasing Bl6 -BL6 cels, multiple injections of r 
hTIMP-2 also resulted in the reduced number of 
pulmonary metastases. In addition to these 
antimetastatic effects, a slightly inhibitory effect on 
the tumor cell growth was observed in vitro and in 
vivo. In conclusion, the antimetastasis by r-hTIMP-
2 may be due to the inhibition of the degradation of 
extracellular matrix by MMPs and to the suppres-
sion of the tumor cell growth. 
7 ) Saiki I. : Review : Cell adhesion molecules and 
cancer metastasis. Jpn. J. Pharmacol., 75 (3) : 
215-242, 1997. 
The adhesive interaction between tumor cells and 
host cells or the extracellular matrix (ECM) plays 
a crucial role in metastasis formation. Therefore, 
understanding the mechanism controlling metas-
tasis may assist in the development of antimetas-
tatic therapy. We have used synthetic or recom-
binant polypeptide analogues containing the Arg 
Gly Asp (RGD) sequence found in the functional 
domains of fibronectin, such as poly(RGD) or CH 
271, to regulate the mechanisms involved in cell 
adhesion during the metastatic process. Poly (RGD) 
Antimetastatic and antitumor effect of a 
recombinant human tissue inhibitor of metal-
lo-proteinases-2 in murine melanoma models. 
Biol. Pharm. Bull., 20 (8): 843-849, 1997. 
Tumor metastasis into distinct organs and tis-
sues, of which many patients with malignancies 
died, is regulated in multisteps. As one of the main 
causes of metastasis, the imbalance between the 
degradative activities of matrix metalloproteinases 
(MMPs) and their specific inhibitors in host, includ-
ing tissue inhibitors of metalloproteinases 
(TIMPs), is well documented. Using a murine 
metastasis model, in which highly metastatic B16 
BL6 melanoma cells were i.v. inoculated into 
syngeneic C57BL/6 mice, administrations of recom-
binant human TIMP-2 (r-hTIMP 2) once a day on 
days 1 to 3 postimplantation significantly inhibited 
the formation of metastatic foci in lungs. The 
antimetastatic effect of r hTIMP 2 was detected 
irrespective of administratir routes [i.v., i.p., s.c 
and i.m. routes] and in a dose dependent manner 
(Fig. 6). The i.m. injections of r-hTIMP-2 at 2-day 
intervals during the early phase after tumor inocula-
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Fig. 6 Effect of r hTIMP 2 on Lung Metastasis 
of i.v. Inoculated B16 BL6 Cells 
Bl6 BL6 cells ( 1×104 cells/0.1 ml) were im-
planted into a mouse tail vein and r hTIMP-2 
was given parenterally once a day on days-1 to 
3 after tumor inoculation via an i.v.-route. The 
untreated mice served as the control.時Tice
were sacrificed and the number of metastaic 
nodules on the lung surface was counted on day 
14 after the tumor inoculation. The symbols ( 0 
and十） represent the individual numbers of 
pulmonary metastases and the averages of the 
treatment groups with S.D. (n=4-5), respec-
tively. All the data were statistically analyzed 
using Kruskal W allis/Dunu tests : 
本ρ＜0.05，叫ρ＜0.01 vs. the control group. 
inhibited experimental lung and liver metastasis 
effectively when coinjected i.v. with various types 
of tumors. In a model of spontaneous lung metas-
tasis using the B16 BL6 melanoma, repeated admin-
istration of this polypeptide before or after surgical 
excision of the primary tumor resulted in a signifi田
cant inhibition of tumor metastasis without affect-
ing the growth of the primary tumor, and substan-
tially prolonged the survival time of mice. The 
mechanism responsible for the inhibition of tumor 
metastasis by the polypeptides is at least partly 
associated with the ability to interfere with cellular 
functions such as adhesiveness, motility and 
invasiveness in the process of metastasis. Combined 
treatment of the CH 271 fusion polypeptide and 
anticancer drugs, i.e. anti adhesion therapy com-
bined with chemotherapy, caused a marked inhibi-
tion of lung and liver metastasis of tumors as 
compared with either treatment alone or with the 
control. In contrast, the promotion of tumor cell 
interaction with immune cells via cel adhesion 
molecules, which differs from the anti adhesive 
mechanism, may lead to the induction of anti tumor 
immune responses and, consequently, to the inhibi-
tion of tumor metastasis. The transfection of the 
gene of B7 1 adhesion molecule into tumor cells 
(B16 BL6 or K1735 M2 melanoma) resulted in the 
remarkable reduction of lung metastasis caused by 
the i.v. injection into mice. Immunization of B7 -
transfected tumor was effective as a tumor vaccine 
for preventing the metastasis of B7 negative origi-
nal tumor cels. Thus, the regulation of the adhesive 
interaction with tumor cells may provide a new and 
promising approach for the control and prevention 
of cancer metastasis. 
8) Wakabayashi C., Hasegawa H., Murata J.and 
Saiki I.: In vivo anti-metastatic action of 
ginseng protopanaxadiol saponins is based on 
their intestinal bacterial metabolites after 
oral administration. Oncol. Res, 9: 411-417, 
1997. 
The present study demonstrated in vivo and in 
vitro anti-metastatic activities of a major intestinal 
bacterial metabolite Ml formed from protopanax-
adiol saponins of Ginseng (the root of Panαx gin-
seng C. A. Meyer) in comparison with its whole 
standardized extract and ginsenosides Rb1, Rb2, and 
Rc (Fig. 7). Although Ginseng extract (1 mg/ 
mouse) and ginsenosides (0.5 mg/mouse) signifi-
cantly inhibited lung metastasis produced by i.v. 
injection of B16 BL6 melanoma cells in syngeneic 
mice (27 61 % of untreated control), they hardly 
inhibited the invasion and migration of B16-BL6 
melanoma and HT1080 fibrosarcoma cells in vitro. 
However the intestinal bacterial metabolite Ml 
inhibited lung metastasis of melanoma cells and in 
vitro tumor cel invasion and migration at non 
toxic or marginally toxic concentrations. Addition-
The root of 
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Fig. 7 Isolation and chemical structure of gin 
senosides and their metabolite. Glc，βD glucopyr-
anosyl; Arap，α一L-arabinopyranosyl; Araf，αL 
arabinofuranosyl.. 
aly, pharmacokinetic studies of ginsenoside Rbl 
and Ml after oral administration (2 mg/mouse) 
revealed that intact Rb1 was not detectable in serum 
for 24 h by HPLC analysis, whereas the level of Ml 
in the serum reached maximum at 8 h (8.5±0.4 μg/ 
ml) after Rb1 administration and at 2 h (10.3±1.0 
μg/ml) after Ml administration. These findings 
suggest that the in vivo anti metastatic effect by 
oral administration of ginsenosides is mediated by 
their metabolic component Ml. 
。学会報告等
1 ）済木育夫：癌の悪性化進展と十全大補湯，平成8
































































































































































































































































































より抑制できることを報告してきた (Jpn.J. Cancer 





































































会大会， 1997, 8, 30-31，大阪．


























































( dialysate : MW < lOOkDa ）と非透析画分（non

































































































30) Ohnishi Y., Fujii H., Sakamoto T., Fujimaki 
M. and Saiki I. : A new pseudo-peptide of Arg -
Gly-Asp (RGD) with inhibitory properties of 
tumor metastasis and enzymatic degradation 
of extracellular matrix. 50th Annual Sympo・
sium on Fundamental Cancer Research 
“Molecular Determinants of Cancer Metas-
tasis", 1997, 10, 28-31, Houston. 
In order to augment the inhibitory effect on 
tumor invasion and metastasis, we here synthesized 
a new pseudo peptides of RGD sequence (FC 336) 
and examined its inhibitory effects on tumor metas-
tasis in vivo and on adhesion, migration and inva-
sion in vitro. FC~336 significantly inhibited experi-
mental lung metastasis produced by i.v. co-injection 
with Bl6 BL6 melanoma or colon 26 M3.l cells in a 
dose-dependent manner. The intraportal injection 
of FC 336 with highly metastatic colon 26 L5 cells 
resulted in a marked reduction of tumor colonies in 
the liver and the liver weights to the normal level. 
However, the co-injection of tumor cells with a high 
dose of RGDS tetrapeptide led to a slight inhibition 
of liver metastasis. The multiple i.v. administration 
of FC-336 after the inoculation of tumor cells into 
the portal vein caused significant inhibition of liver 
metastasis. FC-336 significantly enhanced the sur-
vival rate of mice as compared to the untreated 
controls when injected intraportally with tumor 
cells or intravenously administered after the tumor 
inoculation. Furthermore, FC-336 effectively inhib-
ited the invasion, migration and adhesion of tumor 
cells in vitro, but its inhibitory effects were not 
more than RGDS peptide. Zymography analysis 
revealed that FC 336 inhibited the degradation of 
gelatin substrate by matrix metalloproteinases 
(MMPs) produced by tumor cels, while RGDS 
peptide did not affect the enzymatic degradation. 
These findings indicate that the pseudo-peptides of 
RGD sequence, possessing inhibitory property of the 
degradation by MMPs differently from original 
RGD-containing peptides, may provide an advan-
tage and useful basis for preventing tumor metas-
tasis. 
Key words; Arg-Gly-Asp-Ser (RGDS), pseudo pep-







32) Nishikawa N., Komazawa H., Orikasa A., 
61 
Yamaguchi J., Kojima M., Ono M., Itoh I., 
Azuma I., Fujii H., Murata J. and Saiki I.: 
Synthesis and biological properties of par・
tially modified retro and retro-inverso pseudo 
peptides of Arg-Gly-Asp (RGD). The Seventh 
International Kyoto Conference on New 
Aspects of Organic Chemistry IKCOC-7., 
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Colon 26 L5細胞に TAC101, ATRAを添加し，細胞
死誘導作用を検討した。 3) Gelatin zymograhpy ; 





































た。 2 ）浸潤阻害効果；上層に Matrigel™，下層にFi”
bro nee tinを塗布したhapto-invasionassay系を作製
し， HGF処理により誘導される JHH7細胞の浸潤に
対する TAC-101, A TRAの阻害効果を検討した。 3)





製し， TAC101, A TRAと既存抗癌剤の延命効果を検
討した。


















36) Ohnishi Y., F吋iH., Sakamoto T., Fujirnaki 
M. and Saiki I. : A new pseudo-peptide ana-
logue of Arg-Gly-Asp (RGD) inhibits liver 
metastasis of colon 26-L5 carcinoma cels. 
14th Asia Pacific Cancer Conference/4th 
Hong Kong International Cancer Congress , 
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